Inventor · disambiguated record
Jonathan James Loughrey
Also filed as: LOUGHREY JONATHAN · LOUGHREY JONATHAN J · LOUGHREY JONATHAN JAMES
16 granted patents·6 pending applications·33 citations·filing 2017–2025
91Inventor score
Files withINSPIRNA INC4ACTIMED THERAPEUTICS LTD3ALDEYRA THERAPEUTICS INC3FERRING BV3NIMBUS LAKSHMI INC2
Top patents by PatentIndex Score
22 records- 0194US11878956B2Metal salts and uses thereofINSPIRNA INC·Filed 2022·Granted Jan 23, 2024·2 cites·10 claims
- 0294US11312692B1Polymorphic compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2021·Granted Apr 26, 2022·11 cites·19 claims
- 0392US11174220B2Metal salts and uses thereofINSPIRNA INC·Filed 2020·Granted Nov 16, 2021·2 cites·7 claims
- 0491US11459292B2Metal salts and uses thereofINSPIRNA INC·Filed 2021·Granted Oct 4, 2022·2 cites·5 claims
- 0590US12258303B2Metal salts and uses thereofINSPIRNA INC·Filed 2023·Granted Mar 25, 2025·1 cites·19 claims
- 0687US11673918B2Method of manufacturing a pharmaceutical compositionFERRING BV·Filed 2021·Granted Jun 13, 2023·2 cites·13 claims
- 0786US10336752B2TYK2 inhibitors, uses, and methods for production thereofNIMBUS LAKSHMI INC·Filed 2018·Granted Jul 2, 2019·5 cites·16 claims
- 0883US10981955B2Method of manufacturing a pharmaceutical compositionFERRING BV·Filed 2018·Granted Apr 20, 2021·3 cites·25 claims
- 0982US11040967B2TYK2 inhibitors, uses, and methods for production thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Jun 22, 2021·3 cites·18 claims
- 1081US12029735B2Polymorphic compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2021·Granted Jul 9, 2024·1 cites·21 claims
- 1179US12006298B2Polymorphic compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2019·Granted Jun 11, 2024·1 cites·20 claims
- 1274US12139558B2Method of manufacturing a pharmaceutical compositionFERRING BV·Filed 2023·Granted Nov 12, 2024·0 cites·12 claims
- 1370US2024423955A1Organic acid addition salts of s-pindololACTIMED THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1466US2025302806A1Organic acid addition salts of s-pindololACTIMED THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 1562US12109192B2Organic acid addition salts of S-pindololACTIMED THERAPEUTICS LTD·Filed 2021·Granted Oct 8, 2024·0 cites·11 claims
- 1659US2024239750A1Pharmaceutical preparationAERIE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1751US2025034129A1CRYSTALLINE FORMS OF (6S,7S)-6-FLUORO-7-(2-FLUORO-5-METHYLPHENYL)-3-(TETRAHYDRO-2H-PYRAN-4-YL)-5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONEMYOKARDIA INC·Filed 2023·Application pending·0 cites
- 1850US11767319B2Crystalline forms of a selective c-kit kinase inhibitorTHIRD HARMONIC BIO INC·Filed 2021·Granted Sep 26, 2023·0 cites·24 claims
- 1948US10800801B2Crystalline platinum-based compoundsAKAMARA THERAPEUTICS INC·Filed 2017·Granted Oct 13, 2020·0 cites·23 claims
- 2047US2023391729A1Succinate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the sameALZPROTECT·Filed 2021·Application pending·0 cites
- 2145US2023105181A1Salts and polymorphic forms of 6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1h-pyrazol-4-yl)-3h-imidazo[4,5-b]pyridineELLIPSES PHARMA LTD·Filed 2021·Application pending·0 cites
- 2240US12378245B2Crystalline forms of an RSK inhibitorPHOENIX MOLECULAR DESIGNS·Filed 2020·Granted Aug 5, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Jonathan James Loughrey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →